Long-Term Outcomes of Two Different Initial Dosing Regimens of Intravitreal Ranibizumab Used to Treat Myopic Choroidal Neovascularization
2012 ◽
Vol 90
(7)
◽
pp. e574-e575
◽
2016 ◽
Vol 57
(10)
◽
pp. 1604
◽
2020 ◽
Vol 36
(2)
◽
pp. 122-125
◽
2019 ◽
Vol 60
(6)
◽
pp. 547
◽